Rubenstein David M.
- SEC CIK
- 0001543895
In the past year, 3 open-market sale filings worth $75.8M and no purchases.
Current role at each company
- CG Carlyle Group Inc.Directoras of Sep 11, 2026
- MRNA Moderna, Inc.Directoras of May 8, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $75.8M
- 3 filings
- Net
- −$75.8M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Rubenstein David M. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CG Carlyle Group Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 (view filing)5:11 PM ET | Sep 11 | Same day | Rubenstein David M.Director | SSale | −400.0K | $42.74 | −$17.1M | −1.5%26.9M after | |
| Mar 20, 2026 (view filing) | Mar 19 | 1 day | Rubenstein David M.Director | SSale | −500.0K | $46.68 | −$23.3M | −1.8%27.4M after | |
| Dec 12, 2025 (view filing) | Dec 10 | 2 days | Rubenstein David M.Director | SSale | −625.0K | $56.55 | −$35.3M | −2.2%28.0M after | |
| Jun 6, 2022 (view filing) | Jun 6 | Same day | Rubenstein David M.Director | SSale | −2.00M | $38.67 | −$77.3M | −6.4%29.2M after | |
| Nov 10, 2021 (view filing) | Nov 9 | 1 day | Rubenstein David M.Director | SSale | −2.00M | $58.00 | −$116.0M | −6.0%31.2M after | |
| Aug 13, 2021 (view filing) | Aug 11-13 | 2 days | Rubenstein David M.Director | SSale | −4.00M | $47.10 | −$188.4M | −10.7%33.2M after | 3 lots |